Literature DB >> 34372618

Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia.

Rowa Y Alhabbab1,2, Ahdab Alsaieedi1,2, Abdullah Algaissi3,4, Sara Almahboub1, Rajaa M Al-Raddadi5, Omaima I Shabouni6, Rahaf Alhabbab7, Abdulelah A Alfaraj8, Sawsan S Alamri1, Najwa D Aljehani1,9, Rwaa H Abdulal1,10, Mohamed A Alfaleh1,11, Turki S Abujamel1,2, Almohanad A Alkayyal12, Ahmad Bakur Mahmoud13, Adel M Abuzenadah2, Anwar M Hashem1,14.   

Abstract

Healthcare workers (HCWs) are at high risk for SARS-CoV-2 infection compared to the general population. Here, we aimed to evaluate and characterize the SARS-CoV-2 seropositivity rate in randomly collected samples among HCWs from the largest referral hospitals and quarantine sites during the peak of the COVID-19 epidemic in the city of Jeddah, the second largest city in Saudi Arabia, using a cross-sectional analytic study design. Out of 693 participants recruited from 29 June to 10 August 2020, 223 (32.2%, 95% CI: 28.8-35.8) were found to be confirmed seropositive for SARS-CoV-2 antibodies, and among those 197 (88.3%) had never been diagnosed with COVID-19. Seropositivity was not significantly associated with participants reporting COVID-19 compatible symptoms as most seropositive HCW participants 140 (62.8%) were asymptomatic. The large proportion of asymptomatic SARS-CoV-2 cases detected in our study demands periodic testing as a general hospital policy.

Entities:  

Keywords:  COVID-19 pandemic; HCWs; Jeddah; SARS-CoV-2; anti-S Abs; seroprevalence

Year:  2021        PMID: 34372618     DOI: 10.3390/v13071413

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  8 in total

1.  Perspective on the challenges of COVID-19 facing healthcare workers.

Authors:  Jaffar A Al-Tawfiq; Mohamad-Hani Temsah
Journal:  Infection       Date:  2022-07-04       Impact factor: 3.553

2.  Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon.

Authors:  Omar Bahlawan; Rebecca Badra; Hanna Semaan; Nancy Fayad; Mina Nabil Kamel; Ahmed N El Taweel; Mokhtar R Gomaa; Abeer Sirawan; Atika Berry; Jacques Mokhbat; Jimi Goldstein; Jad Abdallah; Ghazi Kayali
Journal:  Arch Virol       Date:  2022-05-21       Impact factor: 2.685

3.  Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies.

Authors:  Osman O Radhwi; Hamza Jan; Abdullah Waheeb; Sawsan S Alamri; Hatem M Alahwal; Iuliana Denetiu; Ashgan Almanzlawey; Adel F Al-Marzouki; Abdullah T Almohammadi; Salem M Bahashwan; Ahmed S Barefah; Mohamad H Qari; Adel M Abuzenadah; Anwar M Hashem
Journal:  Vaccines (Basel)       Date:  2022-01-20

4.  Community-Based Seroprevalence of SARS-CoV-2 Antibodies following the First Wave of the COVID-19 Pandemic in Jazan Province, Saudi Arabia.

Authors:  Abdulaziz Alhazmi; Edrous Alamer; Siddig Abdelwahab; Nizar Khamjan; Abdullah Hamami; Moayad Haddad; Majid Darraj; Anwar M Hashem; Abdullah Algaissi
Journal:  Int J Environ Res Public Health       Date:  2021-11-26       Impact factor: 3.390

5.  A Cohort Study of Seroprevalence of Antibodies Against SARS-CoV-2 Infection Among Healthcare Workers at a Tertiary Hospital in Saudi Arabia.

Authors:  Hayat Mushcab; Jaffar A Al-Tawfiq; Mohammed Ghamdi; Amani Babgi; Abdulrazack Amir; Salwa S Sheikh; Adel Darwisheh; Abrar Alobaid; Arulanantham Zechariah Jebakumar; Saeed Qahtani; Ahmed Al Sagheir
Journal:  Infect Drug Resist       Date:  2022-08-10       Impact factor: 4.177

6.  High Seroprevalence of SARS-CoV-2 IgG and RNA among Asymptomatic Blood Donors in Makkah Region, Saudi Arabia.

Authors:  Kamal H Alzabeedi; Raafat T M Makhlof; Rowaida A Bakri; Ashraf A Ewis; Heba W Alhamdi; Turki M A Habeebullah; Asim A Khogeer; Eman A A Mulla; Safiah A M Roshan; Fadel H Qabbani; Fayez H Hafez; Rehab G Alqurashi; Muhammad O Babalghaith; Ahmad A Ghouth; Mohammed H Alhazmi; Othman M Fallatah; Saeed A Badahdah; Duaa I A Endergiri; Boshra M Albarakati; Sayed F Abdelwahab
Journal:  Vaccines (Basel)       Date:  2022-08-08

Review 7.  Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.

Authors:  Iman Dandachi; Waleed Aljabr
Journal:  Front Microbiol       Date:  2022-08-31       Impact factor: 6.064

Review 8.  Development of Serological Assays and Seroprevalence Studies of the New Coronavirus 2019 (COVID-19): Reports from Saudi Arabia.

Authors:  Thamir A Alandijany; Arwa A Faizo
Journal:  Healthcare (Basel)       Date:  2021-12-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.